Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers-Reference-Cited by-同舟云学术

Safety and pharmacokinetics of the CIME combination of drugs and their metabolites after a single oral dosing in healthy volunteers

Published:2014-12-03 Issue:2 Volume:41 Page:125-138
ISSN:0378-7966
Container-title:European Journal of Drug Metabolism and Pharmacokinetics
language:en
Short-container-title:Eur J Drug Metab Pharmacokinet

Author:

Lenuzza Natacha,Duval Xavier,Nicolas Grégory,Thévenot Etienne,Job Sylvie,Videau Orianne,Narjoz Céline,Loriot Marie-Anne,Beaune Philippe,Becquemont Laurent,Mentré France,Funck-Brentano Christian,Alavoine Loubna,Arnaud Philippe,Delaforge Marcel,Bénech Henri

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology

Link

http://link.springer.com/content/pdf/10.1007/s13318-014-0239-0.pdf

Reference76 articles.

1. Allegaert K, Vanhaesebrouck S, Verbesselt R, van den Anker JN (2009) In vivo glucuronidation activity of drugs in neonates: extensive interindividual variability despite their young age. Ther Drug Monit 31:411–415

2. Bauman JL, Didomenico RJ, Galanter WL (2006) Mechanisms, manifestations, and management of digoxin toxicity in the modern era. Am J Cardiovasc Drugs 6:77–86

3. Borges S, Li L, Hamman MA, Jones DR, Hall SD, Gorski JC (2005) Dextromethorphan to dextrorphan urinary metabolic ratio does not reflect dextromethorphan oral clearance. Drug Metab Dispos 33:1052–1055

4. Bornemann LD, Min BH, Crews T, Rees MM, Blumenthal HP, Colburn WA, Patel IH (1985) Dose dependent pharmacokinetics of midazolam. Eur J Clin Pharmacol 29:91–95

5. Breimer DD, Schellens JH (1990) A ‘cocktail’ strategy to assess in vivo oxidative drug metabolism in humans. Trends Pharmacol Sci 11:223–225

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical Assessment of Phenotyping Cocktails for Clinical Use in an African Context;Journal of Personalized Medicine;2023-07-05

2. Phenotyping Indices of CYP450 and P-Glycoprotein in Human Volunteers and in Patients Treated with Painkillers or Psychotropic Drugs;Pharmaceutics;2023-03-18

3. Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan;Frontiers in Pharmacology;2022-10-24

4. Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan;2022-08-25

5. Evaluation of a six-probe cocktail (caffeine, tolbutamide, omeprazole, dextromethorphan, midazolam, and digoxin) approach to estimate hepatic drug detoxification capability and dosage requirements after a single oral dosing in healthy Chinese volunteers;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-04-08